Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Target-Shaped Combined Halo and Reversed-Halo Sign, an Atypical Chest Ct Finding in Covid-19 Publisher Pubmed



Shaghaghi S1 ; Daskareh M2 ; Irannejad M1 ; Shaghaghi M3 ; Kamel IR3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Research Center for Immunodeficiencies, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Radiology, Ziaeian Hospital, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, United States

Source: Clinical Imaging Published:2021


Abstract

Typical chest CT findings in COVID-19 have been described as bilateral peripheral ground glass opacities, with or without consolidation. Halo sign and reversed halo sign have been reported as atypical imaging findings in this disease. However, to the best of our knowledge, combined presence of these signs has never been reported before. Herein, we present a COVID-19 patient with numerous atypical target-shaped, combined halo and reversed halo pulmonary lesions, in the absence of any other underlying disease. © 2020 Elsevier Inc.
Other Related Docs
9. Findings of Serial Computed Tomography Imaging in Patients With Coronavirus Disease-19, Open Access Macedonian Journal of Medical Sciences (2020)
26. The Role of Medical Imaging in Covid-19, Advances in Experimental Medicine and Biology (2021)
28. Covid-19: Features, Clinical Course and Concerns, Journal of Cellular and Molecular Anesthesia (2020)
29. Sars-Cov-2; What We Know so Far, Archives of Iranian Medicine (2020)
35. Sars-Cov-2–A Tough Opponent for the Immune System, Archives of Medical Research (2020)
40. The Role of Emergency Radiology in Covid-19: From Preparedness to Diagnosis, Canadian Association of Radiologists Journal (2020)
44. Immune-Based Therapeutic Approaches in Covid-19, Biomedicine and Pharmacotherapy (2022)
48. Clinical Manifestations of Covid-19, Advances in Experimental Medicine and Biology (2021)